Abivax S.A.

NASDAQ: ABVX · Real-Time Price · USD
71.89
2.93 (4.25%)
At close: Aug 20, 2025, 3:59 PM
71.80
-0.13%
After-hours: Aug 20, 2025, 07:49 PM EDT

Abivax S.A. Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
144.22M 251.94M 26.94M 60.7M
Short-Term Investments
136K 9.05M 6K 6K
Long-Term Investments
126K 12.3M 71K 214K
Other Long-Term Assets
6.74M 2.89M -2K 2.75M
Receivables
15.66M 19.1M 8.32M 8.34M
Inventory
n/a -5.88M 12.19M 4M
Other Current Assets
n/a 5.88M n/a n/a
Total Current Assets
170.67M 285.97M 36.18M 75.21M
Property-Plant & Equipment
2.67M 877K 323K 93K
Goodwill & Intangibles
25.02M 25.02M 23.52M 32.1M
Total Long-Term Assets
34.56M 41.09M 39.36M 35.15M
Total Assets
205.23M 327.06M 75.54M 109.23M
Account Payables
43.82M 47.22M 15.47M 18.56M
Deferred Revenue
n/a 52K 133K 162K
Short-Term Debt
42.84M 10.23M 29.49M 10.06M
Other Current Liabilities
532K 6.09M 2.87M -385K
Total Current Liabilities
92.83M 70.04M 51.46M 32.26M
Long-Term Debt
52.16M 44.7M 14.84M 40.27M
Other Long-Term Liabilities
18.22M 16.15M 1.22M 10.37M
Total Long-Term Liabilities
71.81M 61.01M 16.89M 51.03M
Total Liabilities
164.64M 131.05M 68.36M 83.3M
Total Debt
97.36M 55.46M 49.23M 51.65M
Common Stock
633K 629K 223K 168K
Retained Earnings
-438.88M -282.95M -143.51M -81.81M
Comprehensive Income
-75K 112K n/a 1K
Shareholders Equity
40.58M 196.01M 7.19M 25.93M
Total Investments
136K 21.35M 77K 220K